Keywords: Novartis, Zortress, USA, FDA, Certican, Afinitor

US FDA approves Novartis’ Zortress for kidney transplant rejection

Article | 22 April 2010

Print This

The US Food and Drug Administration has approved Swiss drug major Novartis’ Zortress (everolimus) oral tablets for the prevention of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in